PCSK9 and atherosclerosis: PCSK9 was shown as a crucial player in hypercholesterolaemia and atherosclerosis pathophysiology (Fig. 3), while its inhibition decreased the level of LDL-C, reduced the inflammation response in the arterial wall and attenuated atherosclerotic plaque development [120].